Christian Griñan-Ferré was awarded with best communication in the XL National Meeting of Spanish Society of Pharmacology that was presented as a poster as well as selected for oral communication. Research work entitled Discovery of a Dual-Action of G9a Inhibitors for the Treatment of Alzheimer’s Disease outlined the last discoveries by his group under the project entitled validation of dual inhibition G9A / GSK-3B as a new therapeutic strategy for cognitive impairment and Alzheimer’s disease (PID2022-139016OA-I00) Subprograma Estatal de Formación del Programa Estatal para Desarrollar, Atraer y Retener Talento, en el marco del Plan Estatal de Investigación Científica, Técnica y de Innovación 2021-2023.
Ainoa Sánchez was finalist for the Tony B Travel Award in the XV Spanish Drug Discoverny Network (SDDN)
Last week, Ainoa Sanchez Arfelis, our PhD student from Prof. Carmen Escolano’s group, had the opportunity to present her thesis project at…
November 27, 2023
